区域腹主动脉瘤筛查项目10年结局
该研究回顾性分析2007—2016年某区域退伍军人健康系统内19649例接受腹主动脉瘤(AAA)超声筛查的患者,评估AAA诊断率与筛查标准依从性。10年总体AAA诊断率为6.3%,较前5年的7.2%下降;筛查依从性从2007年的61.7%升至2016年的92.4%,AAA相关死亡率为0.03%。
要点
- 10年总体AAA诊断率6.3%,前5年为7.2%,诊断率下降。
- 近5年检出更多小动脉瘤(3.0-4.4 cm),≥5.5 cm者减少。
- 筛查依从性从2007年61.7%升至2016年92.4%,10年总体81.3%。
核心结论
- 10年总体AAA诊断率为6.3%,AAA相关死亡率为0.03%。
- 近5年检出更多小动脉瘤(3.0-4.4 cm),≥5.5 cm的AAA减少。
- 54例AAA≥5.5 cm患者经筛查后成功择期修复。
- 筛查依从性从2007年61.7%显著改善至2016年92.4%,10年总体为81.3%。
研究设计与样本
- 回顾性图表审查,纳入2007至2016年某区域退伍军人健康系统内所有接受AAA筛查的患者。
- 共筛查19649例患者,年龄70.7±4.8岁(均值±标准差)。
- 筛查标准为65至75岁、终生吸烟至少100支的男性;AAA定义为主动脉最大直径≥3 cm。
- 比较前5年与10年总体的AAA诊断率及筛查标准临床依从率。
主要发现
- 10年内共识别1232例动脉瘤,占全部患者的6.3%。
- AAA诊断率从首个5年的7.2%降至10年总体的6.3%(下降13.5%;P < .01)。
- 66例患者AAA≥5.5 cm(占AAA的5.3%),其中54例接受成功择期修复。
- 分析期间2321例患者死亡(11.8%),其中6例疑似AAA破裂死亡(0.03%)。
- 3680例(18.7%)不符合筛查标准:593例<65岁,3087例>75岁,59例为女性;该比例从首个5年的28.2%降至10年总体的18.7%(下降33.7%;P < .01)。
关键数值与推荐
- 筛查标准:65至75岁、终生吸烟至少100支的男性。
- AAA定义:主动脉最大直径≥3 cm。
- AAA诊断率:首个5年7.2%,10年总体6.3%(P < .01)。
- 筛查依从性:2007年61.7%,2016年92.4%,10年总体81.3%(P < .01)。
临床怎么用
- 区域筛查项目可有效识别AAA,并促成AAA≥5.5 cm患者成功择期修复。
- 应持续监测并提高对筛查标准的依从性,减少不符合标准者的筛查。
- 筛查中检出的小动脉瘤(3.0-4.4 cm)比例增加,需对应随访管理。
局限性
- 本研究为单区域退伍军人健康系统的回顾性图表审查,结果外推需谨慎。
- AAA相关死亡通过终末诊断记录或尸检报告识别,可能存在漏判。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In 2007, Medicare established ultrasound screening guidelines to identify patients at risk for abdominal aortic aneurysm (AAA). The purpose of this study was to evaluate AAA diagnosis rates and compliance with screening during 10 years (2007-2016) of the Screen for Abdominal Aortic Aneurysms Very Efficiently Act implementation within a regional health care system. METHODS: A retrospective chart review of all patients screened for AAA from 2007 to 2016 within a regional Veterans Affairs health care system was conducted. Screening criteria were men 65 to 75 years of age who smoked a minimum of 100 cigarettes in their lifetime. An AAA was defined as a maximum aortic diameter ≥3 cm. A comparison was made of the AAA diagnosis rate and clinical adherence rate of screening criteria between the first 5 years and total years evaluated. AAA-related mortality was identified by using terminal diagnosis notes or autopsy reports. All data were recorded by August 31, 2017. RESULTS: A total of 19,649 patients (70.7 ± 4.8 years of age, mean ± standard deviation) were screened from January 1, 2007, to December 31, 2016. There were 9916 new patients screened from 2012 to 2016. A total of 1232 aneurysms (6.3% total patients) were identified during the 10-year period. The overall AAA diagnosis rate has declined from 7.2% in the first 5 years to 6.3% in 10 years (13.5% decrease; P < .01). There were 66 patients found with AAA ≥5.5 cm (5.3% of AAAs), and 54 of these patients received successful elective repair. A total of 2321 patients died (11.8%) and 6 deaths were suspected AAA ruptures (0.03%) within the analysis period. A total of 3680 patients screened (18.7%) did not meet screening criteria: 593 patients were <65 years of age, 3087 patients were >75 years of age, and 59 patients were women. This rate has declined from 28.2% within the first 5 years to 18.7% overall in 10 years (33.7% decrease; P < .01). The compliance of screened patients using screening criteria improved significantly from 61.7% in 2007 to 92.4% in 2016 (P < .01). The overall compliance rate since implementation of the screening program during the past 10 years is 81.3%. CONCLUSIONS: The overall 10-year rate of AAA diagnosis is 6.3%. There are more smaller aneurysms (3.0-4.4 cm) detected and fewer large AAAs ≥5.5 cm in the last 5 years compared with the first 5 years of the screening program. The overall AAA-related mortality rate of all screened patients is 0.03%. There were 54 patients with AAA ≥5.5 cm who underwent successful elective repair resulting from the AAA screening program. The overall compliance of screened patients using screening criteria improved significantly from 61.7% in 2007 to 81.3% since implementation of the screening program during the past 10 years.
引用
- Chun KC, Dolan KJ, Smothers HC, et al. The 10-year outcomes of a regional abdominal aortic aneurysm screening program. J Vasc Surg. 2019. PMID: 30922750. doi:10.1016/j.jvs.2019.01.053
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。